Beyond gut microbiota: Understanding obesity and type 2 diabetes

Hormones

Volumn 14, Issue 3, 2015, Pages 358-369

  Lau, Eva ^a   Carvalho, Davide ^a   Pina Vaz, Cidália ^b   Barbosa, José Adelino ^c   Freitas, Paula ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b Innovation and Development Fernando Pessoa Foundation   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Diabetes; Gut microbiota; Obesity

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; CANNABINOID 1 RECEPTOR; CD14 ANTIGEN; ENDOCANNABINOID; LIPOPOLYSACCHARIDE; MONOSACCHARIDE; POLYSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 4;

BARIATRIC SURGERY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DYSBIOSIS; ENDOTOXEMIA; ENERGY EXPENDITURE; FERMENTATION; HUMAN; INTESTINE ABSORPTION; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LIPID METABOLISM; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; REVIEW; ROUX Y ANASTOMOSIS; COMPLICATION; DIABETES MELLITUS, TYPE 2; PHYSIOLOGY;

DIABETES MELLITUS, TYPE 2; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; HUMANS; OBESITY;

EID: 84938488483     PISSN: 11093099     EISSN: 25208721     Source Type: Journal    
DOI: 10.14310/horm.2002.1571     Document Type: Review

References (95)

1. WHO | Obesity and overweight. [cited 2014 Feb 8]; Available from: http://www.who.int/mediacentre/factsheets/ fs311/en/
2. WHO | Diabetes. [cited 2014 Feb 8]; Available from: http://www.who.int/mediacentre/factsheets/fs312/en/
3. Cani PD, Delzenne NM, 2009 The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 15: 1546-1558.
4. Qin J, Li R, Raes J, et al, 2010 A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65.
5. Prakash S, Rodes L, Coussa-Charley M, Tomaro- -Duchesneau C, 2011 Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics 5: 71-86.
6. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI, 2005 Host-bacterial mutualism in the human intestine. Science 307: 1915-1920.
7. Prakash S, Rodes L, Coussa-Charley M, Tomaro- Duchesneau C, 2011 Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics 5: 71-86.
8. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI, 2005 Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 102: 11070-11075.
9. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI, 2006 An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
10. Ley RE, Turnbaugh PJ, Klein S, Gordon JI, 2006 Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023.
11. Furet J, Kong L, Tap J, et al, 2010 Differential Adaptation of Human Gut Microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59: 3049-3057.
12. Kong LC, Wuillemin P-H, Bastard J-P, et al, 2013 Insulin resistance and inflammation predict kinetic body weight changes in response to dietary weight loss and maintenance in overweight and obese subjects by using a Bayesian network approach. Am J Clin Nutr 98: 1385-1394.
13. Le Chatelier E, Nielsen T, Qin J, et al, 2013 Richness of human gut microbiome correlates with metabolic markers. Nature 500: 541-546.
14. Geurts L, Lazarevic V, Derrien M, et al, 2011 Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front Microbiol 2: 1-17.
15. Larsen N, Vogensen FK, van den Berg FWJ, et al, 2010 Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5: e9085.
16. Qin J, Li Y, Cai Z, et al, 2012 A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490: 55-60.
17. Karlsson FH, Tremaroli V, Nookaew I, et al, 2013 Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498: 99-103.
18. Amar J, Serino M, Lange C, et al, 2011 Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia 54: 3055-3061.
19. Cani PD, Amar J, Iglesias MA, et al, 2014 Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
20. Cani PD, Neyrinck AM, Fava F, et al, 2007 Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50: 2374-2383.
21. Laugerette F, Vors C, Géloën A, et al, 2011 Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J Nutr Biochem 22: 53-59.
22. Poggi M, Bastelica D, Gual P, et al, 2007 C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 50: 1267-1276.
23. Fasano A, 2011 Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev 91: 151-175.
24. Sonier B, Patrick C, Ajjikuttira P, Scott FW, 2009 Intestinal immune regulation as a potential diet-modifiable feature of gut inflammation and autoimmunity. Int Rev Immunol 28: 414-445.
25. Groschwitz KR, Hogan SP, 2009 Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol 124: 3-22.
26. Lamprecht M, Bogner S, Schippinger G, et al, 2012 Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial. J Int Soc Sports Nutr 9: 45.
27. Xiao S, Fei N, Pang X, et al, 2014 A gut microbiotatargeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol Ecol 87: 357-367.
28. Klaus DA, Motal MC, Burger-Klepp U, et al, 2013 Increased plasma zonulin in patients with sepsis. Biochem medica 23: 107-111.
29. Cani PD, Bibiloni R, Knauf C, et al, 2008 Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481.
30. Cani PD, Possemiers S, Van De Wiele T, et al, 2009 Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2- driven improvement of gut permeability. Gut 58: 1091-1103.
31. Estall JL, Drucker DJ, 2006 Glucagon-like Peptide-2. Annu Rev Nutr 26: 391-411.
32. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, 2003 Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
33. Blüher M, Engeli S, Klöting N, et al, 2006 Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 55: 3053-3060.
34. Côté M, Matias I, Lemieux I, et al, 2007 Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Int J Obes 31: 692-699.
35. Silvestri C, Di Marzo V, 2013 The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab 17: 475-490.
36. Muccioli GG, Naslain D, Bäckhed F, et al, 2010 The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 6: 392.
37. Alhamoruni A, Wright KL, Larvin M, O'Sullivan SE, 2012 Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability. Br J Pharmacol 165: 2598-2610.
38. Lallès J-P, 2010 Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet. Nutr Rev 68: 323-332.
39. Koyama I, Matsunaga T, Harada T, Hokari S, Komoda T, 2002 Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. Clin Biochem 35: 455-461.
40. De La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE, 2010 Propensity to high-fat dietinduced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol 299: G440-448.
41. Bates JM, Akerlund J, Mittge E, Guillemin K, 2004 Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2: 371-382.
42. Ghoshal S, Witta J, Zhong J, de Villiers W, Eckhardt E, 2009 Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 50: 90-97.
43. Ding S, Chi MM, Scull BP, et al, 2010 High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 5: e12191.
44. Ding H, Wang T, Hooper L V, et al, 2004 The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101: 15718-15712.
45. Louis P, Scott KP, Duncan SH, Flint HJ, 2007 Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol 102:1197-1208.
46. Louis P, Flint HJ, 2009 Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294: 1-8.
47. Barcenilla A, Pryde SE, Martin JC, et al, 2000 Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol 66: 1654-1661.
48. Le Poul E, Loison C, Struyf S, et al, 2003 Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 278: 25481-25489.
49. Samuel BS, Shaito A, Motoike T, et al, 2008 Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A 105: 16767-16772.
50. Bjursell M, Admyre T, Göransson M, et al, 2011 Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet. Am J Physiol Endocrinol Metab 300: E211-220.
51. Stappenbeck TS, Hooper LV, Gordon JI, 2002 Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 99: 15451-15455.
52. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI, 2007 Mechanisms underlying the resistance to dietinduced obesity in germ-free mice. Proc Natl Acad Sci U S A 104: 979-984.
53. Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI, 2008 Diet-Induced Obesity Is Linked to Marked but Reversible Alterations in the Mouse Distal Gut Microbiome. Cell Host Microbe 3: 213-223.
54. Vrieze A, Van Nood E, Holleman F, et al, 2012 Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143: 913-916.
55. Mingrone G, Panunzi S, De Gaetano A, et al, 2012 Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366: 1577-1585.
56. Schauer BR, Kashyap SR, Wolski k, et al, 2012 Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes. N Engl J Med 366: 1567-1576.
57. Zhang H, DiBaise JK, Zuccolo A, et al, 2009 Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 106: 2365-2370.
58. Kong L-C, Tap J, Aron-Wisnewsky J, et al, 2013 Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. Am J Clin Nutr 98: 16-24.
59. Liou AP, Paziuk M, Luevano J-M, Machineni S, Turnbaugh PJ, Kaplan LM, 2013 Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 5: 178ra41.
60. Gibson GR, Roberfroid MB, 1995 Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125: 1401-1412.
61. Roberfroid M, Gibson GR, Hoyles L, et al, 2010 Prebiotic effects: metabolic and health benefits. Br J Nutr 104: Suppl 2: 1-63.
62. Soldavini J, Kaunitz JD, 2013 Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity. Dig Dis Sci 58: 2756-2766.
63. Parnell JA, Reimer RA, 2009 Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 89: 1751-1759.
64. Cani PD, Joly E, Horsmans Y, Delzenne NM, 2006 Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr 60: 567-572.
65. Delzenne NM, Cani PD, Neyrinck AM, 2007 Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: Experimental Data. J Nutr 137: Suppl 11: 2547-2551.
66. Cani PD, 2006 Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55: 1484-1490.
67. Cani PD, Dewever C, Delzenne NM, 2004 Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br J Nutr 92: 521-526.
68. Cani PD, Possemiers S, Van de Wiele T, et al, 2009 Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091-1103.
69. Capaldo CT, Nusrat A, 2009 Cytokine regulation of tight junctions. Biochim Biophys Acta 1788: 864-871.
70. Parnell JA, Reimer RA, 2009 Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 89: 1751-1759.
71. Sasaki M, Ogasawara N, Funaki Y, et al, 2013 Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study. BMC Gastroenterol 13: 81.
72. Weickert MO, Arafat AM, Blaut M, et al, 2011 Changes in dominant groups of the gut microbiota do not explain cereal-fiber induced improvement of whole-body insulin sensitivity. Nutr Metab 8: 90.
73. Lappi J, Salojärvi J, Kolehmainen M, et al, 2013 Intake of whole-grain and fiber-rich rye bread versus refined wheat bread does not differentiate intestinal microbiota composition in Finnish adults with metabolic syndrome. J Nutr 143: 648-655.
74. Isken F, Klaus S, Osterhoff M, Pfeiffer AFH, Weickert MO, 2010 Effects of long-term soluble vs. insoluble dietary fiber intake on high-fat diet-induced obesity in C57BL/6J mice. J Nutr Biochem 21: 278-284.
75. Johnson BR, Klaenhammer TR, 2014 Impact of genomics on the field of probiotic research: historical perspectives to modern paradigms. Antonie Van Leeuwenhoek 106: 141-156.
76. Chen J, Wang R, Li X-F, Wang R-L, 2012 Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome. Br J Nutr 107: 1429-1434.
77. Chen JJ, Wang R, Li X, Wang R, 2011 Bifidobacte rium longum supplementation improved high-fat-fedinduced metabolic syndrome and promoted intestinal Reg I gene expression. Exp Biol Med (Maywood) 236: 823-831.
78. Yin Y-N, Yu Q-F, Fu N, Liu X-W, Lu F-G, 2010 Effects of four Bifidobacteria on obesity in high-fat diet induced rats. World J Gastroenterol 16: 3394-3401.
79. Miyoshi M, Ogawa A, Higurashi S, Kadooka Y, 2014 Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. Eur J Nutr 53: 599-606.
80. Park D-Y, Ahn Y-T, Park S-H, et al, 2013 Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS One 8: e59470.
81. Everard A, Belzer C, Geurts L, et al, 2013 Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci 110: 9066-9071.
82. Asemi Z, Zare Z, Shakeri H, Sabihi S-S, Esmaillzadeh A, 2013 Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab 63: 1-9.
83. Ogawa A, Kadooka Y, Kato K, Shirouchi B, Sato M, 2014 Lactobacillus gasseri SBT2055 reduces postprandial and fasting serum non-esterified fatty acid levels in Japanese hypertriacylglycerolemic subjects. Lipids Health Dis 13: 36.
84. Kadooka Y, Sato M, Ogawa A, et al, 2013 Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. Br J Nutr 110: 1696-1703.
85. Arora T, Anastasovska J, Gibson G, et al, 2012 Effect of Lactobacillus acidophilus NCDC 13 supplementation on the progression of obesity in diet-induced obese mice. Br J Nutr 108: 1382-1389.
86. Membrez M, Blancher F, Jaquet M, et al, 2008 Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J 22: 2416-2426.
87. Carvalho BM, Guadagnini D, Tsukumo DML, et al, 2012 Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia 55: 2823-2834.
88. Murphy EF, Cotter PD, Hogan A, et al, 2013 Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut 62: 220-226.
89. Hansen CHF, Krych L, Nielsen DS, et al, 2012 Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia 55: 2285-2294.
90. O'Sullivan O, Coakley M, Lakshminarayanan B, et al, 2013 Alterations in intestinal microbiota of elderly Irish subjects post-antibiotic therapy. J Antimicrob Chemother 68: 214-221.
91. Jernberg C, Löfmark S, Edlund C, Jansson JK, 2010 Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 156: 3216-3223.
92. Jernberg C, Löfmark S, Edlund C, Jansson JK, 2007 Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 1: 56-66.
93. Thuny F, Richet H, Casalta J-P, Angelakis E, Habib G, Raoult D, 2010 Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS One 5: e9074.
94. Ajslev TA, Andersen CS, Gamborg M, Sørensen TIA, Jess T, 2011 Childhood overweight after establishment of the gut microbiota: the role of delivery mode, prepregnancy weight and early administration of antibiotics. Int J Obes 35: 522-529.
95. Hernández E, Bargiela R, Diez MS, et al, 2013 Functional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity. Gut Microbes 4: 306-315.